Home|DSIJArticleDetail

MSCI India Domestic Small Cap Index announces inclusion of 43 stocks which includes GRSE, Mirza International and many more!
MSCI India Domestic Small Cap Index announces inclusion of 43 stocks which includes GRSE, Mirza International and many more!

MSCI India Domestic Small Cap Index announces inclusion of 43 stocks which includes GRSE, Mirza International and many more!

The MSCI India Domestic Small Cap Index since May 30, 2008 has delivered an annualized return of 10.57 per cent as against 5.05 per cent and 9.74 per cent of MSCI Emerging Markets and MSCI India Index, respectively.

Karan Dsij Article rating: 4.0

In its recent review, 43 securities have been added, while 16 securities have been deleted from The MSCI India Domestic Small Cap Index. 

Stocks below Rs 100: Only buyers seen in these scrips on May 23
Stocks below Rs 100: Only buyers seen in these scrips on May 23

Stocks below Rs 100: Only buyers seen in these scrips on May 23

The US equity index S&P 500 briefly fell into bear market territory during Friday’s session but recovered slightly to close almost flat.

Sayali Kotwal Article rating: 4.2

At 11.30 am on Monday, the core equity indices i.e., Sensex and Nifty 50 were trading marginally higher amidst mixed global cues. The Asia Pacific markets showed mixed signs on Monday as global uncertainties continue to worry the investors. 

Stocks to watch: These small-cap stocks will be in focus tomorrow!
Stocks to watch: These small-cap stocks will be in focus tomorrow!

Stocks to watch: These small-cap stocks will be in focus tomorrow!

Mangalore Refinery & Petrochemicals, Meghmani Finechem, Texmaco Rail & Engineering, Chennai Petroleum Corporation, GSS Infotech, Gufic Biosciences, Shoppers Stop, Genus Power Infrastructures, DCM Shriram Industries, Manali Petrochemicals, and Veranda Learning Solutions made a fresh 52-week high today

Armaan Madhani Article rating: 5.0

BSE Smallcap index underperformed broader markets, closing the session with gains of mere 0.36 per cent.

 

DSIJ MINDSHARE

Mkt Commentary15-May, 2024

Penny Stocks15-May, 2024

Bonus and Spilt Shares15-May, 2024

Mindshare15-May, 2024

Swing Trading15-May, 2024

Knowledge

General15-May, 2024

MF14-May, 2024

MF14-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList